Wireless technology for digital x-ray is resulting in increased efficiency in patient throughput, according to a report from Orem, Utah-based market research firm KLAS.

Cancer survivors face an increased risk of anxiety for 10 years or more following diagnosis, according to a study published June 5 in The Lancet Oncology. In addition, their partners face similar levels of depression but even higher rates of anxiety as cancer survivors themselves.

PETNET Solutions, a wholly owned subsidiary of Siemens Medical Solutions USA, Inc., will soon begin manufacturing Eli Lilly and Company’s AmyvidTM (Florbetapir (18F)) radiopharmaceutical in the United Kingdom, as well as in Spain and France, after signing a manufacturing services agreement with Eli Lilly and Company. Siemens’ PETNET Solutions will function as a contract manufacturer for Lilly after Lilly’s diagnostic radiopharmaceutical received marketing authorisation from the European Commission in early 2013.

Nevada has joined the growing number of states that have passed breast density legislation.

IBA (Ion Beam Applications S.A.), the global high-tech leader in next generation radiation therapy and diagnostics for the treatment of cancer, is pleased to announce that today 60 radiation therapy leaders travelled to Belgium to discover the first Proteus®ONE in factory.

Any breast cancer surgeon who regularly performs lumpectomies confronts the question “Did I get it all?” Thirty to 60 percent of the time in the U.S., the answer is “no,” requiring the patient to undergo a second surgery to remove the remaining tumor. Surgeons at UC Irvine Medical Center are the first in the country to use a device that reduces by half the need to reoperate and cut out breast cancer cells missed during an initial lumpectomy.

Out of a range of mathematical methods for managing pulmonary nodules with FDG PET/CT, one quantitative CT technique takes the lead--dynamic area-detector CT analyzed using the dual-input maximum slope method, according to a study published May 22 in the American Journal of Roentgenology.

Four respected organizations promote different guidelines for routine breast cancer screening. The conflicting recommendations place physicians in a bit of a quandary as the broad set of valid options may leave clinicians feeling vulnerable to malpractice suits. A viewpoint published online May 30 in JAMA sorted through the guidelines and offered some suggestions.